Navigation Links
New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohn's Patients
Date:10/26/2009

nventional treatment in September 2007. Health Canada and the European Commission have both approved CIMZIA in combination with methotrexate (MTX), for the treatment of moderate to severe active RA in adult patients inadequately responsive to disease-modifying antirheumatic drugs (DMARDs) including MTX. UCB is also developing CIMZIA in other autoimmune disease indications. CIMZIA is a registered trademark of UCB PHARMA S.A.

IMPORTANT SAFETY INFORMATION

Risk of Serious Infections

Patients treated with CIMZIA are at an increased risk for developing serious infections that may lead to hospitalization or death. Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. CIMZIA should be discontinued if a patient develops a serious infection or sepsis. Reported infections include:

  • Active tuberculosis, including reactivation of latent tuberculosis. Patients with tuberculosis have frequently presented with disseminated or extrapulmonary disease. Patients should be tested for latent tuberculosis before CIMZIA use and during therapy. Treatment for latent infection should be initiated prior to CIMZIA use.
  • Invasive fungal infections, including histoplasmosis , coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients with histoplasmosis or other invasive fungal infections may present with disseminated, rather than localized disease. Antigen and antibody testing for histoplasmosis may be negative in some patients with active infection. Empiric anti-fungal therapy should be considered in patients at risk for invasive fungal infections who develop severe systemic illness .
  • Bacterial, viral and other infections due to opportunistic pathogens.

The risks and benefits of treatment with CIMZIA should be carefully considered prior to initiating th
'/>"/>

SOURCE UCB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
2. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
3. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
4. Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohns Disease
5. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
6. e-Zassi.com Provides Industry With Online U.S. FDA Regulatory Calculator for Rapid Medical Device Technology Assessment
7. Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
8. New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In-Hospital Emergency Personnel
9. CardioGenics Holdings Inc. Provides Update on FINRA Submission Regarding Name Change
10. Young Innovations, Inc. Provides Third Quarter Conference Call Details
11. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... and LONDON , ... era for biopharmaceutical companies. Competition for innovation, increasing ... to keep up with the fast-changing environment are ... influence clinical trials, and clinical trial costs continue ... patient recruitment. Studies conducted by industry ...
(Date:9/18/2014)... , Sept. 18, 2014  ADM Tronics ... DeNovi , Ph.D. to its corporate Advisory Board ... an instructor at the Harvard Medical School and ... Rome.  He received his Masters degree in Electronics ... Systems from the University of Bologna. After spending a ...
(Date:9/18/2014)... , Sept. 18, 2014 MiMedx Group, ... developer, processor and marketer of patent protected regenerative ... announced today that it has entered into a ... MiMedx will provide its dehydrated human amnion/chorion membrane ... non- exclusively on a private label basis. ...
Breaking Medicine Technology:Patient Recruitment in Asia Biotech and Pharma Companies 2Patient Recruitment in Asia Biotech and Pharma Companies 3ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3
... and secondary endpoints of,study; no negative drug-drug ... CAMBRIDGE, Mass., June 12, 2007 /PRNewswire-FirstCall/ -- ... phase II study,designed to evaluate triple combination ... candidate for the,treatment of hepatitis C, pegylated ...
... II Study Demonstrates Significant,Additional Improvement for Patients ... /PRNewswire-FirstCall/ --,Indevus Pharmaceuticals, Inc. today announced that ... for pagoclone in persistent,developmental stuttering will be ... the New Clinical Drug Evaluation Unit (NCDEU), ...
Cached Medicine Technology:Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9
(Date:9/18/2014)... Technology Association of Georgia in collaboration with ... Social Savvy Awards this week at a special ceremony ... in Downtown Atlanta. The event celebrates Georgia’s best and ... honored with the 2014 TAG Social Savvy People’s Choice ... in 6 other award categories: , , ...
(Date:9/18/2014)... (HealthDay News) -- Teens and young adults who,ve been ... that provides them with greater responsibility and independence early ... "We found that having a mentor provides a ... lead author, Steve McDonald, an associate professor of sociology ... news release. In conducting the study, published ...
(Date:9/18/2014)... Research led by Paulo Rodriguez, PhD, an assistant ... Health New Orleans, Stanley S. Scott Cancer Center, has ... Chop plays in the body,s ability to fight cancer. ... the activity and accumulation of cells that suppress the ... Orleans research team showed that when they removed Chop, ...
(Date:9/18/2014)... The Spartan race is known as ... course lengths of 3+miles (Sprint), 8+miles, (Super) and 12+miles ... signature obstacles designed to help participants discover their inner ... a Spartan Race and the feeling of accomplishment that ... and accept people of all ages, backgrounds, and fitness ...
(Date:9/18/2014)... September 18, 2014 Activz ... to announce the release of Activz Coconut Water ... liquid of young, organic coconuts from Thailand. Activz Coconut ... Activz Whole-Food Nutrition revolutionary line of produce powders available ... options. The new Activz Coconut Water Powder will ...
Breaking Medicine News(10 mins):Health News:Winners Honored at 2014 TAG Social Savvy Awards 2Health News:Winners Honored at 2014 TAG Social Savvy Awards 3Health News: Mentors May Steer Young People Toward More Rewarding Careers 2Health News:LSU Health research discovers means to free immune system to destroy cancer 2Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 2Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 3Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 4Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 2Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 3
... BRANFORD, Conn., Sept. 5 CuraGen Corporation,(Nasdaq: CRGN ... that Dr. Frank M. Armstrong, President and Chief,Executive Officer, ... Bear,Stearns 20th Annual Healthcare Conference on Tuesday, September 11, ... held at The Grand Hyatt,New York in New York ...
... Va., Sept. 5 Traditional Latin,American foods have a ... foods that have brought families together for generations are,being ... Oftentimes Latin foods are prepared with high-calorie ingredients ... to the American Diabetes,Association (ADA), eating foods high in ...
... the Canadian Institutes of Health Research (CIHR) unveiled a ... of research it has funded. CIHR will require its ... freely available online within six months of publication. ... is a defining feature of science, and is essential ...
... PHOENIX, Sept. 4 TriWest Healthcare Alliance is,offering an ... have lost a loved one in service to our ... unit commanders, TriWest is partnering,with noted author and nationally ... killed in the line of duty. Through a ...
... MINNEAPOLIS, Sept. 4 HEI, Inc. (Nasdaq: HEII,-- ... closed on the sale of,substantially all of the ... Inc., a wholly-owned subsidiary of Dutch based Smartrac ... substantially all the assets of the,RFID division, including ...
... Brings Over 20 Years Of Experience ... in Sales, Marketing And Operational Excellence, LENEXA, Kan., ... ) announced the appointment of Thomas Kelly,Mann as chief ... than 20 years with 3M,s healthcare information technology,division where ...
Cached Medicine News:Health News:CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 3Health News:Open access to health research publications 2Health News:TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program 2Health News:HEI, Inc. Closes on Sale of RFID Division Assets 2Health News:Mediware Names Thomas K. Mann Chief Executive Officer 2
Resorbable fixation system 1.5/2.0....
... Sonomed-315 is intended for visualization of the ... midline shifts in the brain, evaluation of ... to use, the Sonomed-315 offers quick and ... allows to identify the anatomic structures of ...
... cost, low volume alternative. Whole blood is drawn ... from whole blood by centrifugation in a standard ... Cebus single use cartridge. The cartridge is then ... the concentrating process. Finally, the cartridge is spun ...
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: